Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Cyst 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 7Fluorouracil 7Paclitaxel 5Leucovorin 5pembrolizumab 4Trastuzumab 4Radiation 4Capecitabine 4tislelizumab 3Taxes 3Specimen Handling 3Nivolumab 3Carboplatin 3ulixertinib 2trastuzumab biosimilar HLX02 2patritumab deruxtecan 2Surgical Procedures, Operative 2Radiotherapy 2Pemetrexed 2PF-05280014 2Ontruzant 2Ogivri 2Irinotecan 2Exercise 2Docetaxel 2Cisplatin 2CT-P6 2zolbetuximab 1zimberelimab 1zanidatamab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Defecation × 30 days × Clear all
NCT06123338 2026-05-28

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
49 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡